Average Co-Inventor Count = 4.22
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Renovis, Inc. (10 from 17 patents)
2. Evotec Ag (5 from 24 patents)
3. Fgh Biotech, Inc. (2 from 4 patents)
4. Evotec (us) Inc. (2 from 2 patents)
5. Second Genome, Inc. (10 patents)
6. Evotec Inc. (0 patent)
19 patents:
1. 11497738 - Di-substituted pyrazole compounds for the treatment of diseases
2. 11339142 - Di-substituted pyrazole compounds for the treatment of diseases
3. 9133122 - Amide compounds, compositions and uses thereof
4. 8946439 - Amide compounds, compositions and uses thereof
5. 8859545 - Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and compositions thereof useful for the treatment of inflammatory and respiratory diseases
6. 8779144 - Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
7. 8653091 - Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof
8. 8546579 - [object Object]
9. 8093265 - Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
10. 8076345 - 2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof
11. 7816371 - [object Object]
12. 7745451 - Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and dysfunctions
13. 7576099 - Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
14. 7414131 - Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
15. 7402596 - Bicycloheteroaryl compounds as P2X7 modulators and uses thereof